These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37098956)

  • 1. Diverse Murine Vaccinations Reveal Distinct Antibody Classes to Target Fusion Peptide and Variation in Peptide Length to Improve HIV Neutralization.
    Sastry M; Changela A; Gorman J; Xu K; Chuang GY; Shen CH; Cheng C; Geng H; O'Dell S; Ou L; Rawi R; Reveiz M; Stewart-Jones GBE; Wang S; Zhang B; Zhou T; Biju A; Chambers M; Chen X; Corrigan AR; Lin BC; Louder MK; McKee K; Nazzari AF; Olia AS; Parchment DK; Sarfo EK; Stephens T; Stuckey J; Tsybovsky Y; Verardi R; Wang Y; Zheng CY; Chen Y; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
    J Virol; 2023 May; 97(5):e0160422. PubMed ID: 37098956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
    Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consistent elicitation of cross-clade HIV-neutralizing responses achieved in guinea pigs after fusion peptide priming by repetitive envelope trimer boosting.
    Cheng C; Xu K; Kong R; Chuang GY; Corrigan AR; Geng H; Hill KR; Jafari AJ; O'Dell S; Ou L; Rawi R; Rowshan AP; Sarfo EK; Sastry M; Saunders KO; Schmidt SD; Wang S; Wu W; Zhang B; Doria-Rose NA; Haynes BF; Scorpio DG; Shapiro L; Mascola JR; Kwong PD
    PLoS One; 2019; 14(4):e0215163. PubMed ID: 30995238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein.
    van Haaren MM; McCoy LE; Torres JL; Lee W; Cottrell CA; Copps JL; van der Woude P; Yasmeen A; de Taeye SW; Torrents de la Peña A; Moore JP; Burton DR; Klasse PJ; Ward AB; Sanders RW; van Gils MJ
    J Virol; 2021 Aug; 95(17):e0009421. PubMed ID: 34076487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a Prefusion HIV-1 Envelope Trimer in Complex with a Quaternary-Structure-Specific Antibody.
    Cheng C; Pancera M; Bossert A; Schmidt SD; Chen RE; Chen X; Druz A; Narpala S; Doria-Rose NA; McDermott AB; Kwong PD; Mascola JR
    J Virol; 2015 Dec; 90(6):2740-55. PubMed ID: 26719262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.
    Xu K; Acharya P; Kong R; Cheng C; Chuang GY; Liu K; Louder MK; O'Dell S; Rawi R; Sastry M; Shen CH; Zhang B; Zhou T; Asokan M; Bailer RT; Chambers M; Chen X; Choi CW; Dandey VP; Doria-Rose NA; Druz A; Eng ET; Farney SK; Foulds KE; Geng H; Georgiev IS; Gorman J; Hill KR; Jafari AJ; Kwon YD; Lai YT; Lemmin T; McKee K; Ohr TY; Ou L; Peng D; Rowshan AP; Sheng Z; Todd JP; Tsybovsky Y; Viox EG; Wang Y; Wei H; Yang Y; Zhou AF; Chen R; Yang L; Scorpio DG; McDermott AB; Shapiro L; Carragher B; Potter CS; Mascola JR; Kwong PD
    Nat Med; 2018 Jun; 24(6):857-867. PubMed ID: 29867235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.
    Cheng C; Duan H; Xu K; Chuang GY; Corrigan AR; Geng H; O'Dell S; Ou L; Chambers M; Changela A; Chen X; Foulds KE; Sarfo EK; Jafari AJ; Hill KR; Kong R; Liu K; Todd JP; Tsybovsky Y; Verardi R; Wang S; Wang Y; Wu W; Zhou T; ; Arnold FJ; Doria-Rose NA; Koup RA; McDermott AB; Scorpio DG; Worobey M; Shapiro L; Mascola JR; Kwong PD
    Cell Rep; 2020 Aug; 32(5):107981. PubMed ID: 32755575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
    Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing Antibody Responses following Long-Term Vaccination with HIV-1 Env gp140 in Guinea Pigs.
    Bricault CA; Kovacs JM; Badamchi-Zadeh A; McKee K; Shields JL; Gunn BM; Neubauer GH; Ghantous F; Jennings J; Gillis L; Perry J; Nkolola JP; Alter G; Chen B; Stephenson KE; Doria-Rose N; Mascola JR; Seaman MS; Barouch DH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multivalent clade C HIV-1 Env trimer cocktail elicits a higher magnitude of neutralizing antibodies than any individual component.
    Bricault CA; Kovacs JM; Nkolola JP; Yusim K; Giorgi EE; Shields JL; Perry J; Lavine CL; Cheung A; Ellingson-Strouss K; Rademeyer C; Gray GE; Williamson C; Stamatatos L; Seaman MS; Korber BT; Chen B; Barouch DH
    J Virol; 2015 Mar; 89(5):2507-19. PubMed ID: 25540368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clade C HIV-1 Envelope Vaccination Regimens Differ in Their Ability To Elicit Antibodies with Moderate Neutralization Breadth against Genetically Diverse Tier 2 HIV-1 Envelope Variants.
    Burton S; Spicer LM; Charles TP; Gangadhara S; Reddy PBJ; Styles TM; Velu V; Kasturi SP; Legere T; Hunter E; Pulendran B; Amara R; Hraber P; Derdeyn CA
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptide.
    Wang S; Matassoli F; Zhang B; Liu T; Shen CH; Bylund T; Johnston T; Henry AR; Teng IT; Tripathi P; Becker JE; Changela A; Chaudhary R; Cheng C; Gaudinski M; Gorman J; Harris DR; Lee M; Morano NC; Novik L; O'Dell S; Olia AS; Parchment DK; Rawi R; Roberts-Torres J; Stephens T; Tsybovsky Y; Wang D; Van Wazer DJ; Zhou T; Doria-Rose NA; Koup RA; Shapiro L; Douek DC; McDermott AB; Kwong PD
    Cell Rep; 2023 Jul; 42(7):112755. PubMed ID: 37436899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms.
    Murji AA; Qin JS; Hermanus T; Morris L; Georgiev IS
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete functional mapping of infection- and vaccine-elicited antibodies against the fusion peptide of HIV.
    Dingens AS; Acharya P; Haddox HK; Rawi R; Xu K; Chuang GY; Wei H; Zhang B; Mascola JR; Carragher B; Potter CS; Overbaugh J; Kwong PD; Bloom JD
    PLoS Pathog; 2018 Jul; 14(7):e1007159. PubMed ID: 29975771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.
    Patil S; Kumar R; Deshpande S; Samal S; Shrivastava T; Boliar S; Bansal M; Chaudhary NK; Srikrishnan AK; Murugavel KG; Solomon S; Simek M; Koff WC; Goyal R; Chakrabarti BK; Bhattacharya J
    J Virol; 2016 Jan; 90(7):3446-57. PubMed ID: 26763999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.
    Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL
    Front Immunol; 2020; 11():984. PubMed ID: 32582155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breadth of neutralizing antibodies elicited by stable, homogeneous clade A and clade C HIV-1 gp140 envelope trimers in guinea pigs.
    Nkolola JP; Peng H; Settembre EC; Freeman M; Grandpre LE; Devoy C; Lynch DM; La Porte A; Simmons NL; Bradley R; Montefiori DC; Seaman MS; Chen B; Barouch DH
    J Virol; 2010 Apr; 84(7):3270-9. PubMed ID: 20053749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines.
    Vukovich MJ; Raju N; Kgagudi P; Manamela NP; Abu-Shmais AA; Gripenstraw KR; Wasdin PT; Shen X; Dwyer B; Akoad J; Lynch RM; Montefiori DC; Richardson SI; Moore PL; Georgiev IS
    J Virol; 2024 Jan; 98(1):e0147823. PubMed ID: 38085509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers.
    Schorcht A; van den Kerkhof TLGM; Cottrell CA; Allen JD; Torres JL; Behrens AJ; Schermer EE; Burger JA; de Taeye SW; Torrents de la Peña A; Bontjer I; Gumbs S; Ozorowski G; LaBranche CC; de Val N; Yasmeen A; Klasse PJ; Montefiori DC; Moore JP; Schuitemaker H; Crispin M; van Gils MJ; Ward AB; Sanders RW
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32999024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.